• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

RA Capital Management

edit

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. Their team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and board levels. They invest in companies with promising technologies and products. Their approach is to achieve a superior understanding of data, experimental/trial design, regulatory process, and commercial potential. When appropriate, they can offer their portfolio companies leads on in-licensing opportunities and strategic partnerships, as well as insight into the demands of the public markets.

Recent Milestones

edit

• 
  RA Capital Management invested in bluebird bio. (7/25/12)
  Posted 7/25/12 at 4:35am via yahoo.com
• 
  RA Capital Management invested in OvaScience. (4/3/12)
  Posted 4/4/12 at 4:02am via fiercebiotech.com
• 
  RA Capital Management invested in T2 Biosystems. (8/10/11)
  Posted 8/10/11 at 5:46pm via masshightech.com
• 
  RA Capital Management invested in ADVENTRX Pharmaceuticals. (1/7/11)
  Posted 1/11/11 at 3:08am via fiercebiotech.com
• 
  RA Capital Management invested in T2 Biosystems. (5/26/10)
  Posted 5/26/10 at 5:09pm via onbiovc.com
• 
  RA Capital Management invested in Genelabs Technologies. (6/27/06)
  Posted 4/23/10 at 9:30pm

Investments

Videos

Sources

1. bluebird bio Secures $60 Million in Oversubscribed Financing (in.finance.yahoo.com) [edit]
2. OvaScience grabs $37M B round for fertility treatments (fiercebiotech.com) [edit]
3. T2 Biosystems closes $23M Series D financing (masshightech.com) [edit]
4. Adventrx announces $22.5M capital raise (fiercebiotech.com) [edit]
5. T2 Biosystems, Inc.: Series C $15M (onbiovc.com) [edit]
6. EDGAR [edit]